EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger(Inserm), Mirjam B. Zeisel(Inserm), Fei Xiao(Université de Strasbourg), Christine Thumann(Université de Strasbourg), Isabel Fofana(Université de Strasbourg), Laetitia Zona(Inserm), Christopher Davis(University of Birmingham), Christopher Mee(University of Birmingham), Marine Turek(Inserm), Sebastian Gorke(University of Freiburg), Cathy Royer(Inserm), Benoit Fischer(Université de Strasbourg), Muhammad Zahid(Inserm), Dimitri Lavillette(École Normale Supérieure de Lyon), Judith Fresquet(École Normale Supérieure de Lyon), François–Loïc Cosset(Inserm), S. Michael Rothenberg(Massachusetts General Hospital), Thomas Pietschmann(Center for Experimental and Clinical Infection Research), Arvind H. Patel(MRC University of Glasgow Centre for Virus Research), Patrick Pessaux(Hôpitaux Universitaires de Strasbourg), Michel Doffoël(Hôpitaux Universitaires de Strasbourg), Wolfgang Raffelsberger(Inserm), Olivier Poch(Université de Strasbourg), Jane A. McKeating(University of Birmingham), Laurent Brino(Université de Strasbourg), Thomas F. Baumert(Inserm)
Cited by 691Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis